Hypothesis

Chronic mTOR activity in D1‑receptor‑expressing medium spiny neurons (MSNs) of the dorsolateral striatum sustains the synaptic protein synthesis necessary for goal‑directed, deliberative action. With age‑related dopamine decline, reduced mTOR signaling preferentially weakens D1‑MSN circuitry, tipping the basal ganglia balance toward the D2‑indirect pathway and promoting energetically cheap, habitual responses. Thus, mTOR acts as a cellular ‘civilization‑versus‑survival’ dial within striatal circuits, where its inhibition translates the organism’s metabolic state into a behavioral shift from flexible planning to routine execution.

Mechanistic Rationale

• mTORC1 drives translation of plasticity‑related proteins (e.g., Arc, PSD‑95, GluA1) that stabilize dendritic spines and strengthen corticostriatal synapses in D1‑MSNs, supporting the direct pathway’s role in action selection and outcome evaluation (1).
• Dopamine depletion diminishes D1‑receptor–mediated cAMP/PKA signaling, which normally synergizes with mTOR to promote long‑term potentiation. When both inputs fall, dendritic spine density in D1‑MSNs declines, reducing the signal‑to‑noise ratio for goal‑directed commands.
• D2‑MSNs express higher baseline levels of autophagy‑related genes and are less dependent on mTOR‑driven translation for maintaining their inhibitory output onto the globus pallidus external segment (2). Consequently, indirect‑pathway tone remains relatively preserved, biasing the network toward habitual, stimulus‑response patterns.
• This creates a feedback loop: habitual behavior consumes less ATP, reinforcing low‑nutrient signaling that keeps mTOR suppressed, thereby locking the system into a ‘survival mode’ state.

Testable Predictions

1. Pharmacological inhibition of mTOR (e.g., chronic rapamycin) in young adult mice will accelerate the age‑typical shift from progressive‑ratio lever pressing (goal‑directed) to lever pressing under extinction or devaluation (habitual).
2. Cell‑type‑specific activation of mTORC1 (via Rheb overexpression or TSC1 knockout) in D1‑MSNs of aged mice will rescue goal‑directed performance without altering overall dopamine levels.
3. Conversely, mTOR activation in D2‑MSNs will exacerbate habitual bias, indicating pathway‑specific effects.
4. Biochemically, aged D1‑MSNs will show reduced phospho‑S6 (mTORC1 readout) and decreased spine density, whereas D2‑MSNs will retain comparable phospho‑S6 levels relative to young controls.

Experimental Approach

• Use Cre‑driver lines (D1‑Cre, D2‑Cre) crossed with floxed TSC1 (to activate mTOR) or floxed Raptor (to inhibit mTOR) to achieve MSN‑specific manipulation.
• Subject mice (3‑month young, 18‑month aged) to a two‑step decision task that dissociates goal‑directed from habitual control (3), measuring sensitivity to outcome devaluation and transition probabilities.
• Perform in vivo two‑photon imaging of dendritic spines in dorsolateral striatum before and after behavioral testing.
• Validate pathway activity via phospho‑S6 immunostaining and electrophysiological recordings of evoked EPSCs in D1‑ vs D2‑MSNs.
• Include dopamine‑measurement controls (HPLC) to ensure observed effects are not secondary to global dopaminergic changes.

Potential Outcomes and Falsifiability

• If rapamycin treatment does not increase habitual behavior, or if D1‑specific mTOR activation fails to restore goal‑directed action despite confirmed molecular rescue, the hypothesis would be falsified, indicating that mTOR’s influence on behavioral flexibility operates elsewhere or through non‑synaptic mechanisms.
• Conversely, observing the predicted molecular and behavioral shifts would support the notion that mTOR’s cellular anabolic state directly tunes the D1/D2 balance, providing a mechanistic bridge between the ‘civilization‑versus‑survival’ metaphor and striatal circuit dysfunction in aging.